Clinical Trial Update: Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating oxygen-ozone as adjuvant treatment for early control of COVID-19 progression and modulation of gut microbiota.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Pneumonia Viral

Drugs mentioned

• oxygen-ozone

Snippet

Sponsor: Roberto Poscia MD, PhD | Conditions: COVID, SARS-CoV 2 | Phase 2 | Status: UNKNOWN